{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:32:37Z","timestamp":1787682757274,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although epithelioid angiomyolipoma of the kidney has been studied by several groups, the reported prevalence of malignant behavior remains uncertain and there are not yet definitive predictive biomarkers. We evaluated the behavior of renal epithelioid angiomyolipoma in a consecutive series in a single institution and investigated the prognostic value of aberrant p53 expression and <jats:italic>TFE3<\/jats:italic> gene abnormality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively reviewed 14 epithelioid angiomyolipomas, most with pure or close to pure epithelioid components, comprising 12 consecutive cases who had attended our institution and two consultation cases. Fluorescence in situ hybridization with <jats:italic>TFE3<\/jats:italic> break-apart probe was performed on 14 cases. The 14 cases were also labeled for p53 and TFE3 by immunohistochemistry. All cases were followed up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Three of the epithelioid angiomyolipomas were strongly positive for TFE3 and two had a mutant expression of p53. Although no <jats:italic>TFE3<\/jats:italic> gene rearrangement was found, the two tumors with strong TFE3 expression showed <jats:italic>TFE3<\/jats:italic> gene amplification. Follow-up details were available for seven of the 12 consecutive cases: two of them had developed metastases and died (29%), their mean overall survival was 41\u2009months, and both had mutant p53 expression. The two consultation cases with <jats:italic>TFE3<\/jats:italic> gene amplification developed recurrence\/metastasis within 1 year after surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our series study from a single institution presented the prevalence of malignant behavior in pure epithelioid angiomyolipomas, although the small number of cases with follow-up data greatly reduced the accuracy. p53 may be a prognostic marker for epithelioid angiomyolipoma. Cases with <jats:italic>TFE3<\/jats:italic> gene amplification had poor prognoses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-023-01298-9","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T04:31:48Z","timestamp":1675657908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["p53 aberration and TFE3 gene amplification may be predictors of adverse prognosis in epithelioid angiomyolipoma of the kidney"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3687-2666","authenticated-orcid":false,"given":"Yanning","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"1298_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.2289","volume":"214","author":"CC Pan","year":"2008","unstructured":"Pan CC, Chung MY, Ng KF, Liu CY, Wang JS, Chai CY, et al. Constant allelic alteration on chromosome 16p (TSC2 gene): genetic evidence for the relationship of PEComa with angiomyolipoma. J Pathol. 2008;214:387\u201393.","journal-title":"J Pathol"},{"key":"1298_CR2","first-page":"65","volume-title":"WHO classification of tumors of the urinary system and male genital organs","author":"G Martignoni","year":"2016","unstructured":"Martignoni G, Reuter V, Cheville J, Ro JY, Fletcher CM, Tickoo SK, et al. Mesenchymal tumors occurring mainly in adults. In: Moch H, Humprey PA, Ulbright TM, Reuter VE, editors. WHO classification of tumors of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer; 2016. p. 65\u20136."},{"key":"1298_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/PAS.0b013e31817ed7a6","volume":"33","author":"H Aydin","year":"2009","unstructured":"Aydin H, Magi-Galluzzi C, Lane BR, Sercia L, Lopez JI, Rini BI, et al. Clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. Am J Surg Pathol. 2009;33:289\u201397.","journal-title":"Am J Surg Pathol"},{"key":"1298_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/PAS.0b013e3181d90370","volume":"34","author":"F Brimo","year":"2010","unstructured":"Brimo F, Robinson B, Guo C, Zhou M, Latour M, Epstein JI. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathology prognostic indicators of malignancy. Am J Surg Pathol. 2010;34:715\u201322.","journal-title":"Am J Surg Pathol"},{"key":"1298_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/00000478-200006000-00017","volume":"24","author":"G Martignoni","year":"2000","unstructured":"Martignoni G, Pea M, Rigaud G, Manfrin E, Colato C, Zamboni G, et al. Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases: demonstration of the same genetic defects in the primary and metastatic lesions. Am J Surg Pathol. 2000;24:889\u201394.","journal-title":"Am J Surg Pathol"},{"key":"1298_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/00000478-200202000-00006","volume":"26","author":"G Martignoni","year":"2002","unstructured":"Martignoni G, Bonetti F, Pea M, Tardanico R, Brunelli M, Eble JN. Renal disease in adults with TSC2\/PKD1 contiguous gene syndrome. Am J Surg Pathol. 2002;26:198\u2013205.","journal-title":"Am J Surg Pathol"},{"key":"1298_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/PAS.0b013e318206f2a9","volume":"35","author":"N Nese","year":"2011","unstructured":"Nese N, Martignoni G, Fletcher CD, Gupta R, Pan CC, Kim H, et al. Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol. 2011;35:161\u201376.","journal-title":"Am J Surg Pathol"},{"key":"1298_CR8","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/modpathol.2013.72","volume":"26","author":"W He","year":"2013","unstructured":"He W, Cheville JC, Sadow PM, Gopalan A, Fine SW, Al-Ahmadie HA, et al. Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors. Mod Pathol. 2013;26:1355\u201364.","journal-title":"Mod Pathol"},{"issue":"suppl","key":"1298_CR9","first-page":"539","volume":"2","author":"G Martignoni","year":"1995","unstructured":"Martignoni G, Pea M, Bonetti F. Renal epithelioid oxyphilic neoplasm (REON), a pleomorphic variant of renal angiomylipoma (abstract). In J Surg Pathol. 1995;2(suppl):539.","journal-title":"In J Surg Pathol"},{"key":"1298_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2020.151538","volume":"47","author":"O Boudaouara","year":"2020","unstructured":"Boudaouara O, Kallel R, Dhieb D, Smaoui W, Ayed HB, Keskes L, et al. Renal angiomyolipoma: Clinico-pathologic study of 17 cases with emphasis on the epithelioid histology and p53 gene abnormalities. Ann Diagn Pathol. 2020;47:151538.","journal-title":"Ann Diagn Pathol"},{"key":"1298_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2559.2009.03420.x","volume":"55","author":"H Faraji","year":"2009","unstructured":"Faraji H, Nguyen BN, Mai KT. Renal epithelioid angiomyolipoma: a study of six cases and a meta-analytic study. Development of criteria for screening the entity with prognostic significance. Histopathology. 2009;55:525\u201334.","journal-title":"Histopathology."},{"key":"1298_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.prp.2008.04.008","volume":"204","author":"K Sato","year":"2008","unstructured":"Sato K, Ueda Y, Tachibana H. Malignant epithelioid angiomyolipoma of the kidney in a patient with tuberous sclerosis: an autopsy case report with p53 gene mutation analysis. Pathol Res Pract. 2008;204:771\u20137.","journal-title":"Pathol Res Pract"},{"issue":"10","key":"1298_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/pin.12458","volume":"66","author":"JH Park","year":"2016","unstructured":"Park JH, Lee C, Suh JH, Kim G, Song B, Moon KC. Renal epithelioid angiomyolipoma: histopathologic review, immunohistochemical evaluation and prognostic significance. Pathol Int. 2016;66(10):571\u20137.","journal-title":"Pathol Int"},{"issue":"4","key":"1298_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/00000478-200204000-00017","volume":"26","author":"K Kawaguchi","year":"2002","unstructured":"Kawaguchi K, Oda Y, Nakanishi K, Saito T, Tamiya S, Nakahara K, et al. Malignant transformation of renal angiomyolipoma: a case report. Am J Surg Pathol. 2002;26(4):523\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1298_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/1066896912441829","volume":"20","author":"Z Bing","year":"2012","unstructured":"Bing Z, Yao Y, Pasha T, Tomaszewski JE, Zhang PJ. P53 in pure epithelioid PEComa: an immunohistochemistry study and gene mutation analysis. Int J Surg Pathol. 2012;20(2):115\u201322.","journal-title":"Int J Surg Pathol"},{"key":"1298_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1477-7819-10-213","volume":"10","author":"J Li","year":"2012","unstructured":"Li J, Zhu M, Wang YL. Malignant epithelioid angiomyolipoma of the kidney with pulmonary metastases and p53 gene mutation. World J Surg Oncol. 2012;10:213.","journal-title":"World J Surg Oncol"},{"key":"1298_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00795-012-0584-5","volume":"45","author":"C Ohe","year":"2012","unstructured":"Ohe C, Kuroda N, Hes O, Michal M, Vanecek T, Grossmann P, et al. A renal epithelioid angiomyolipoma\/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH. Med Mol Morphol. 2012;45:234\u20137.","journal-title":"Med Mol Morphol"},{"key":"1298_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00428-014-1655-x","volume":"465","author":"Q Shen","year":"2014","unstructured":"Shen Q, Rao Q, Xia QY, Yu B, Shi QL, Zhang RS, et al. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features. Virchows Arch. 2014;465:607\u201313.","journal-title":"Virchows Arch"},{"key":"1298_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/PAS.0000000000000631","volume":"40","author":"K Pivovarcikova","year":"2016","unstructured":"Pivovarcikova K, Grossmann P, Alaghehbandan R, Sperga M, Michal M, Hes O. TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers. Am J Surg Pathol. 2016;40:723\u201337.","journal-title":"Am J Surg Pathol"},{"key":"1298_CR20","first-page":"22081","volume":"13","author":"P Argani","year":"2019","unstructured":"Argani P, Zhang L, Sung YS, White MJ, Miller K, Hopkins M, et al. A novel RBMX-TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumor. Genes Chromosomes Cancer. 2019;13:22081.","journal-title":"Genes Chromosomes Cancer"},{"key":"1298_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/path.5470","volume":"251","author":"XT Wang","year":"2020","unstructured":"Wang XT, Fang R, Zhang RS, Ye SB, Li R, Wang X, et al. Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification. J Pathol. 2020;251:365\u201377.","journal-title":"J Pathol"},{"key":"1298_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/PAS.0000000000000502","volume":"39","author":"Q Rao","year":"2015","unstructured":"Rao Q, Shen Q, Xia QY, et al. PSF\/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity. Am J Surg Pathol. 2015;39:1181\u201396.","journal-title":"Am J Surg Pathol"},{"key":"1298_CR23","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41379-018-0051-5","volume":"31","author":"XT Wang","year":"2018","unstructured":"Wang XT, Xia QY, Ye SB, Wang X, Li R, Fang R, et al. RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations. Mod Pathol. 2018;31:1346\u201360.","journal-title":"Mod Pathol"},{"issue":"1","key":"1298_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pathol.2020.08.008","volume":"53","author":"A Cali\u00f2","year":"2021","unstructured":"Cali\u00f2 A, Brunelli M, Segala D, Zamboni G, Bonetti F, Pea M, et al. Angiomyolipoma of the kidney: from simple hamartoma to complex tumor. Pathology. 2021;53(1):129\u201340.","journal-title":"Pathology."},{"key":"1298_CR25","first-page":"505","volume":"46","author":"ZG Yao","year":"2017","unstructured":"Yao ZG, Rao Q, Qin YJ, Sun XC. Renal malignant epithelioid angiomyolipoma with X chromosome polyploid TFE3 gene amplification: a case report. China J Pathol. 2017;46:505\u20136.","journal-title":"China J Pathol"},{"key":"1298_CR26","first-page":"639","volume":"28","author":"Q Shen","year":"2012","unstructured":"Shen Q, Rao Q, Yu B. Renal epithelioid angiomyolipoma with TFE3 amplification. J Clin Exp Pathol. 2012;28:639\u201342.","journal-title":"J Clin Exp Pathol"},{"issue":"6","key":"1298_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5414\/CNCS109443","volume":"24","author":"H Wang","year":"2018","unstructured":"Wang H, Zhan HY, Yao ZG, Liu QW. Malignant renal epithelioid angiomyeolipoma with TFE3 gene ampilification mimicking renal carcinoma. Clin Nephrol Case Stud. 2018;24(6):11\u20135.","journal-title":"Clin Nephrol Case Stud"},{"key":"1298_CR28","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","volume":"34","author":"P Argani","year":"2010","unstructured":"Argani P, Aulmann S, Illei PB, Netto GJ, et al. A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol. 2010;34:1395\u2013406.","journal-title":"Am J Surg Pathol"},{"key":"1298_CR29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/modpathol.2017.144","volume":"31","author":"A Cali\u00f2","year":"2018","unstructured":"Cali\u00f2 A, Brunelli M, Segala D, Pedron S, Tardanico R, Remo A, et al. t (6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa\/epithelioid angiomyolipoma. Mod Pathol. 2018;31:474\u201387.","journal-title":"Mod Pathol"},{"key":"1298_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pathol.2019.11.006","volume":"52","author":"A Cali\u00f2","year":"2020","unstructured":"Cali\u00f2 A, Brunelli M, Segala D, Pedron S, Tardanico R, Remo A, et al. Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets. Pathology. 2020;52:297\u2013309.","journal-title":"Pathology."}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01298-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-023-01298-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01298-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T04:35:42Z","timestamp":1675658142000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-023-01298-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1298"],"URL":"https:\/\/doi.org\/10.1186\/s13000-023-01298-9","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,6]]},"assertion":[{"value":"20 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures in this study were conducted in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and its later versions. Ethical approval was obtained from the ethical review board of Beijing Friendship Hospital, Capital Medical University (No: 2022-P2-004-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}